CME Group Inc. (NASDAQ:CME) Shares Sold by Pitcairn Co.

Pitcairn Co. trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 6.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,741 shares of the financial services provider’s stock after selling 186 shares during the quarter. Pitcairn Co.’s holdings in CME Group were worth $605,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CME. Ameriprise Financial Inc. increased its stake in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Raymond James & Associates raised its holdings in shares of CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after acquiring an additional 94,302 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after acquiring an additional 176,004 shares during the last quarter. PineStone Asset Management Inc. lifted its position in shares of CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after acquiring an additional 1,309,097 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of CME Group by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,981,961 shares of the financial services provider’s stock valued at $437,320,000 after acquiring an additional 26,642 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CME. Barclays boosted their target price on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Piper Sandler boosted their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday, October 28th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research report on Tuesday, October 8th. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Finally, Oppenheimer raised their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $224.47.

CME Group Trading Up 0.1 %

Shares of CME stock opened at $229.37 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.74. The firm’s 50 day moving average price is $223.86 and its two-hundred day moving average price is $211.19. The stock has a market cap of $82.66 billion, a price-to-earnings ratio of 24.12, a price-to-earnings-growth ratio of 5.28 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the business posted $2.25 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. CME Group’s payout ratio is currently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.